Clindamycin Hydrochloride
Product Images NDC 21695-034

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clindamycin Hydrochloride (NDC 21695-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Da1d371a 5541 468f 985b 6e4e214b7c16 01)

FDA Label Image

Clindamycin HCl 150mg (Da1d371a 5541 468f 985b 6e4e214b7c16 02)

FDA Label Image

Clindamycin HCl 300mg (Da1d371a 5541 468f 985b 6e4e214b7c16 03)

Clindamycin HCl 300mg (Da1d371a 5541 468f 985b 6e4e214b7c16 03)
This is a description of a medication containing 300mg of Clindamycin HCI per capsule. The lot number and expiration date are provided on the label, along with the product identification number. The medication is manufactured by a company called Ot Ladcraorme located in North Brunswick. The prescription medication is available only by Rx.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.